Europe PMCopen access
Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associated with increased risk of clinical progression in early Alzheimer's disease
Alzheimer’s disease, Glial fibrillary acidic protein (GFAP), Cerebrospinal fluid (CSF), Mild Cognitive Impairment, Subjective Memory Decline, Blood Biomarkers Of Alzheimer’s Disease
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 182053
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.